Certified by Founder Lodge
T-Therapeutics Ltd
United Kingdom - Cambridge
START UP
1 Disclosed Funding Rounds $59,707,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
T-Therapeutics is a next-generation TCR company, spun out from the University of Cambridge, deeply rooted in world-leading academic science. We are developing ‘optimal’ TCR based therapeutic
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 16 ,2023 | Series A | $59,707,000 | |
| November, 18 ,2025 | Series A | $32,000,000.00 |
Digitalis Ventures
Sofinnova Partners
Cambridge Innovation Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Govstream.ai | $3,600,000 | (Dec 5, 2025)
ZincFive, Inc. | $30,000,000 | (Dec 5, 2025)
imper.ai | $28,000,000 | (Dec 5, 2025)
SPhotonix Inc | $4,500,000 | (Dec 5, 2025)
Multifactor (YC F25) | $15,000,000 | (Dec 5, 2025)
